Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Archemix Reduces Aperture to Pursue Orphan Diseases

Apr 01 2008

Related Content

OSI Buys Eyetech, Market Rubs Eyes

Sep 01 2005

Ophthotech Raises $36 million, In-licenses Aptamers

Sep 01 2007

Finding the Opportunities in Aptamers

Mar 01 2004

Aptamers: Two Deals Down, One Big Deal Up

Apr 01 2005

Related Companies

Archemix Corp.

Sanofi Genzyme

Alexion Pharmaceuticals Inc.

BioMarin Pharmaceutical Inc.

Pfizer Inc.

OSI Systems, Inc.

Anesiva, Inc.

Bristol Myers Squibb Company

Idera Pharmaceuticals, Inc.

Dynavax Technologies Corporation

Gilead Sciences, Inc.

SomaLogic, Inc.

Ionis Pharmaceuticals, Inc.

Genentech, Inc.

UCB S.A.

Merck & Co., Inc.

Antisoma plc

Iveric Bio, Inc.

Regado Biosciences, Inc.

Merck KGaA

Merck KGaA

Alnylam Pharmaceuticals Inc.

GSK plc

Bristol Myers Squibb Company

Roche Holding AG

Roche Holding AG

Nuvelo

Baxter International Inc.

Elan Corporation

Takeda Pharmaceutical Co. Ltd.

Additional Topics

Strategy Business Strategies Regulation BioPharmaceutical

More from Business Strategy

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window